Late-Stage Translational Research

Photo of Mayo Clinic CCaTS staff in a classroom

CCaTS Late-Stage Translational Research partners with multidisciplinary stakeholders to investigate and support the translation of proven interventions into practice and policy. Collaborations include the Mayo Clinic Evidence-Based Practice Research Program, the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, and the Mayo Clinic Care Network.

Late-Stage Translational Research has also been referred to as "T2" or "T3" translational research, which focuses on getting the best available science into routine clinical care. Interventions that are proven in the laboratory and clinical trials must be adapted and made available to work in the context of patients' lives, clinical practice and the health care system.

There are many practical and organizational problems involved in translating good science into the care of patients and populations. Late-Stage Translational Research investigators design and conduct studies to solve those challenges. This work is essential in ensuring that the value of the investment in research is realized as improved outcomes.

Late-Stage Translational Research in CCaTS is concerned with understanding the complex factors that impact the:

  • Integration of health care into the lives of patients and its fit within their values, preferences, context and abilities
  • Optimal and practical delivery of health care within different care environments
  • Dissemination and implementation of evidence-based interventions into guidelines, policies and routine practice

We offer consultative services in Dissemination and Implementation Science.